88 results
8-K
EX-99.1
EXEL
Exelixis Inc
6 Feb 24
Exelixis Announces Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Corporate Update
4:28pm
on the cabozantinib experience and the integrated research, development and commercial capabilities highlighted at our recent R&D Day, we are working … to build multiple franchises across the Exelixis portfolio. As we concentrate our R&D resources on our product development activities, we remain focused
8-K
EX-99.1
EXEL
Exelixis Inc
8 Jan 24
Results of Operations and Financial Condition
9:06am
–
– Fiscal year 2024 net product revenues guidance of $1,650 million - $1,750 million;
2024 R&D expense guidance of $925 million - $975 million … –
– Implementing corporate restructuring to focus R&D resources on clinical stage and IND-enabling activities to maximize pipeline success
8-K
EX-99.1
EXEL
Exelixis Inc
1 Nov 23
Exelixis Announces Third Quarter 2023 Financial Results and Provides Corporate Update
4:08pm
. We’ll discuss all these updates and more at our R&D Day on Tuesday, December 12th in New York City. I’d like to thank the entire Exelixis team … strategy at its R&D Day in December 2023; the potential for XL309 to be a best-in-class small molecule inhibitor of USP1; Exelixis’ updated 2023
8-K
EX-99.1
x2qet38svd jic7o
1 Aug 23
Exelixis Announces Second Quarter 2023 Financial Results and Provides Corporate Update
4:11pm
DEFA14A
021r4ywh5k my9
16 May 23
Additional proxy soliciting materials
6:33pm
DEFA14A
ok3 plkkbkbqen64sq
15 May 23
Additional proxy soliciting materials
8:05am
DFAN14A
4g053 fzp521
11 May 23
Additional proxy materials by non-management
12:27pm
DFAN14A
gp272mq6f
8 May 23
Additional proxy materials by non-management
11:59am
DFAN14A
l5bbl6vy4cl88fuiazf3
3 May 23
Additional proxy materials by non-management
2:18pm
DEFC14A
86p96j2l0fsq
3 May 23
Proxy in contested solicitation
10:28am
DEFA14A
EX-1
hefc1zquyeoihs4
1 May 23
Additional proxy soliciting materials
8:55pm
DEFA14A
qouirbwb6w32lbfrqim
1 May 23
Additional proxy soliciting materials
5:12pm
DEFC14A
5fbkdmbls67xfy qtoq
1 May 23
Proxy in contested solicitation
4:58pm
PRRN14A
y3slsktpar
21 Apr 23
Revised preliminary proxy statement filed by non-management
5:04pm
PREC14A
0ushz0 ty6z31
17 Apr 23
Preliminary proxy with contested solicitation
4:57pm
PREC14A
ptd3qnqorppcct3h7n4o
6 Apr 23
Preliminary proxy with contested solicitation
5:27pm
DEFA14A
xw9o5pq i7nj1ydu0z
5 Apr 23
Additional proxy soliciting materials
9:23pm
DFAN14A
p4l4wj ti
5 Apr 23
Additional proxy materials by non-management
12:38pm